SXTC
China SXT Pharmaceuticals Inc
NASDAQ: SXTC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.06
+0.49% today
Updated 2026-04-30
Market cap
$2.00M
P/E ratio
—
P/S ratio
1.30x
EPS (TTM)
$-57.15
Dividend yield
—
52W range
$1 – $368
Volume
0.1M
China SXT Pharmaceuticals Inc (SXTC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $182472.00 | $293042.00 | $1.92M | $239192.00 | $934247.00 | $-1.32M | $268293.00 | $-80757.00 | $-1.93M | $-2.35M |
| Capital expenditures | $96991.00 | $186308.00 | $1.05M | $610085.00 | $406658.00 | $93044.00 | $62490.00 | $70684.00 | $7063.00 | $2023.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $2.00 | $11.00 | $5.69M | $1.27M | $2.33M | $554571.00 | $352100.00 | $0.00 |
| Free cash flow | $85481.00 | $106734.00 | $869436.00 | $-370893.00 | $527589.00 | $-1.41M | $205803.00 | $-151441.00 | $-1.94M | $-2.35M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $2.38M | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — |